Barcelona-based DeepUll raised €50 million in Series C funding to validate UllCORE, a rapid sepsis diagnostic tool. The test identifies 95% of sepsis pathogens within an...
Leo Pharma’s Spanish unit earned €97M in 2024, up 4% from 2023, led by dermatology (€61.2M, 67% of revenue). Biodermatology grew over 20%, driven by Adtralza....
Biospain 2025, Spain’s top biotech event, returns to Barcelona October 7–9, uniting global innovation with local expertise. Key topics include AI in healthcare, green biotech, and...
Spain has executed 82% of public and 56% of private investments in the Vanguard Health Plan, aiming to modernize healthcare through precision medicine, digital transformation, and...
Healthcare technology should be replaced every ten years, with proper maintenance throughout its lifecycle to ensure safety, accuracy, and efficiency. Fenin’s new guide, based on Cocir’s...
Biotechnology has surged in Galicia, especially Pontevedra, now second only to Catalonia. The sector generates €1.5 billion annually, 2% of Galician GDP, with significant growth post-COVID....
Spain’s public healthcare spending rose to €97.66 billion in 2023, up 6.2%. Pharmaceutical spending hit a historic low share of 14.3% despite nominal growth. Public health...
Bioga and CESGA strengthen their 15-year collaboration to boost Galicia’s biotech sector using high-performance computing. Their joint efforts aim to cut drug development costs and time,...
A Carlos III Health Institute team showed CRISPR-based gene therapy effectively targets Ewing sarcoma in preclinical models. Using a tumor-specific promoter, the treatment avoids harming healthy...
CNIC researchers have developed a promising gene therapy for ARVC5, a lethal genetic heart disease. By delivering a healthy TMEM43 gene via AAV vectors, they improved...